Pediatric Clinic Revenue in India: What ₹18 L–₹1.8 Cr a Year Actually Covers

Pediatric clinic revenue in India runs ₹18 L to ₹1.8 Cr a year, drawn from ICG's own engagement base across pediatric clients, not an outside survey. The spread comes down to one thing: how many clinicians work under one roof and how many service lines sit alongside consultation and immunisation, not how much a single visit costs. A single-pediatrician OPD practice sits at the ₹18 L end; a multi-pediatrician child-health centre with vaccination programmes and added services sits near ₹1.8 Cr.

Contents

• What the ₹18 L–₹1.8 Cr range actually measures
• City and tier: why the same clinic earns differently in different places
• The cost base a pediatric clinic's revenue has to cover
• What makes up that revenue: the visit calendar behind it
• Break-even: fixed costs against a schedule-driven revenue line
• The over-extrapolation mistake owners make with this range
• FAQ

What the ₹18 L–₹1.8 Cr range actually measures

The ₹18 L–₹1.8 Cr figure is an annual revenue number, not a setup cost, and it comes from ICG's own engagement base across pediatric clinic clients. Pediatric clinic revenue in India at the ₹18 L end describes a single pediatrician running an OPD practice built around consultation and immunisation. At the ₹1.8 Cr end it describes something closer to a small child-health centre: several pediatricians, a running vaccination programme, developmental and behavioural services, sometimes pediatric dentistry or nutrition alongside, and occasionally day-care observation beds for short-stay cases that don't need a full hospital admission — an adjacency ICG covers separately at the hospitals industry page.

That factor-of-ten gap is worth sitting with, because it isn't explained by pricing. Pediatric consultation fees have a low ceiling almost everywhere in India; a clinic can't charge its way from ₹18 L to ₹1.8 Cr by raising the visit fee. What moves the number is service breadth and clinician count — more pediatricians seeing more patients, plus revenue lines beyond the consult itself.

Pediatric clinic income in India is a different question from revenue, and worth separating early. Revenue is the top line this range describes — everything billed before rent, salaries and supplies are paid. Income, or profit, is what's left after the cost base in the next section is cleared, and it sits well below the revenue figure at either end of the range.

City and tier: why the same clinic earns differently in different places

The more useful question for an owner isn't "what will my clinic earn" — it's how large a pediatric population the clinic can actually reach, and at what fee ceiling. That reframes tier and city from background detail into the two variables that decide where inside the ₹18 L–₹1.8 Cr range a given clinic actually lands. The same service mix, run in two different cities, produces two different revenue outcomes, and neither city is doing anything wrong.

A dense Tier 1 catchment supports more pediatricians and a wider service line because there's simply a larger addressable population of families within a reasonable commute. Consultation fee ceilings also run higher in Tier 1 metros than in Tier 2 or Tier 3 towns, which pushes a Tier 1 clinic of identical size toward the upper half of the range. A Tier 2 or Tier 3 clinic with the same clinician count and the same services will land lower, purely because the local fee ceiling and the reachable population are both smaller — not because the clinic is run worse. Entry capital follows the same tier logic, laid out in more depth at ICG's clinic setup cost breakdown.

The cost base a pediatric clinic's revenue has to cover

Pediatrics doesn't buy a cath lab, a linac or an operating theatre, and that absence is the first thing worth naming about this specialty's cost base. There's no imaging stack to license, no implant inventory to carry, no OT staffing to fund around the clock. That single fact is why entry capital for a pediatric clinic sits well below what a surgical or imaging-led specialty demands before it can bill anything at all.

What the cost base does carry:

• Waiting-room and consultation space sized for children and parents together, not a single adult patient at a time.
• Longer consultation slots than an adult OPD visit typically needs, because a pediatric consult usually has to work with both the child and a parent.
• A vaccine cold chain — refrigeration capital and the ongoing discipline of maintaining it, whether the clinic runs a small unit or a larger one.
• Clinical Establishments Act registration and biomedical waste authorisation, the licensing floor every clinical premises has to clear regardless of specialty. Per the official Clinical Establishments Act portal, the Act "provides for registration and regulation of clinical establishments in the country with a view to prescribe basic minimum standards of facilities and services." Biomedical waste handling carries its own authorisation obligation under the Biomedical Waste Management Rules, 2016, described in the government's press release on the Rules.

Child clinic setup cost in India, seen this way, is the floor a clinic's revenue has to clear every month before anything counts as profit — light on equipment, heavier on space and clinician time than the low headline capital figure might suggest.

Because equipment isn't the constraint, clinician hours are. A single pediatrician can only see so many patients in a working day no matter how well the space is used, which is exactly why the revenue ceiling on a one-doctor clinic sits near ₹18 L and why reaching the top of the range requires adding clinicians, not just filling more of one doctor's schedule.

What makes up that revenue: the visit calendar behind it

A pediatric patient's visit calendar is knowable years in advance, and that single mechanic is what sets pediatric clinic revenue apart from specialties that have to win each episode of care afresh. A child enrolled for immunisation at birth returns on a schedule defined by the national immunisation programme, then keeps returning for well-child checks well past the point where the immunisation series itself is complete. No cardiac, orthopedic or gynecology patient relationship works this way as a matter of standard care.

Whether a clinic stocks and administers vaccines itself or refers patients to a separate vaccination centre is a real margin decision sitting underneath this table, not a settled default. Stocking vaccines means carrying cold-chain capital and wastage risk on unused doses. Referring out avoids that capital and risk but hands the recurring contact — and the well-child revenue that tends to follow it — to whoever administers the vaccine instead.

Pediatric clinic profitability is a separate question from this revenue composition. The table above describes what generates the top line; how much of it survives as profit depends on the cost base covered earlier and the fixed-versus-variable split covered next.

Break-even: fixed costs against a schedule-driven revenue line

Fixed costs and variable costs split differently here than in most specialties, and that split is the organising fact behind pediatric clinic break-even. Rent, core clinician salaries and the cold-chain equipment run every month regardless of how many visits actually happen; consumables and any staffing added for optional services move with actual patient volume. A clinic can be fully staffed and still short of break-even in a slow month, because the fixed side of the ledger doesn't shrink to match a quiet week.

There's a genuine advantage buried in this, though it comes with a catch. Because the immunisation schedule is externally defined and known years in advance, a pediatric clinic's future visit volume is more forecastable than an acquisition-driven specialty's, which makes break-even timing more tractable to model here than in a business that has to win each new patient from scratch. The catch is seasonality: respiratory and infectious presentations cluster at certain times of year, so monthly revenue swings even though the annual figure looks stable end to end. An owner who divides the annual range by twelve and expects that number every month will misjudge cash flow in the leaner months, even if the clinic hits its annual target exactly.

The over-extrapolation mistake owners make with this range

The most common modelling mistake is assuming straight-line growth toward the top of the ₹18 L–₹1.8 Cr range from a strong month one or year one. That assumption is wrong on its own terms: the top of the range isn't reached by seeing more patients through the same OPD hours with the same pediatrician. It requires adding clinician count and adding service lines — vaccination programmes, developmental services, pediatric dentistry, nutrition — that a single-doctor practice simply doesn't have room to run. Pediatrician clinic earnings, read as the clinic's total revenue rather than as anyone's personal pay, scale in steps tied to headcount and service breadth, not in a smooth line tied to one practitioner's calendar filling up.

A second version of the same mistake treats the annual figure as a flat monthly average, which the seasonality point above already rules out. And a third shows up specifically around vaccines: an owner who decides to self-administer without the volume to justify the cold-chain investment ends up carrying wastage risk that a referral arrangement would have avoided entirely, eating into margin at exactly the revenue level meant to fund the expansion.

On a retention-driven specialty like this one, cost per qualified lead is the wrong single metric to run a marketing budget against. Lifetime value across a multi-year visit calendar matters more than what any single new patient costs to acquire, because the value of that patient compounds over years of scheduled returns rather than ending at the first visit. No pediatrics row currently exists in ICG's published benchmark table — no published specialty benchmark exists; see CPQL benchmarks for national average methodology. What does exist is a specialty-agnostic result: a 38–58% reduction in cost per qualified lead within the first 90 days of onboarding, drawn from ICG's CPQL benchmarks, based on 46 active healthcare client engagements across a rolling 12-month window from July 2025 to July 2026, spanning Delhi NCR, Mumbai, Bangalore, Chennai, Hyderabad and Kolkata, last verified 26 July 2026. Marketing spend as a share of a pediatric clinic's opex is engagement-specific and clinic-model-dependent; see CPQL benchmarks for methodology. For a broader look at how that spend gets structured across specialties, see ICG's healthcare marketing agency page.

FAQ

What is average annual revenue for a pediatric clinic in India? It runs ₹18 L to ₹1.8 Cr a year, based on ICG's own engagement base rather than a market survey. A single-pediatrician OPD practice sits near the bottom; a multi-pediatrician child-health centre with added service lines sits near the top.

How much of that revenue comes from immunisation versus consultation fees? Both are recurring, but immunisation carries a scheduling advantage consultation alone doesn't have, since it's tied to a nationally defined schedule rather than parent-initiated visits. The exact split isn't something ICG has a published figure for, but immunisation contact is what tends to pull families back for well-child visits afterward.

Should a pediatric clinic administer vaccines itself or refer to a vaccination centre? It's a genuine margin trade-off, not a default either way. Stocking vaccines means carrying cold-chain capital and wastage risk; referring out avoids that cost but hands the recurring patient contact to someone else.

Why does pediatric clinic revenue vary by a factor of ten between the low and high end of the range? Consultation fees have a low ceiling almost everywhere, so ticket size isn't the lever. Clinician count and service breadth — vaccination programmes, developmental services, dentistry, nutrition, day-care observation — are what push a clinic toward the top of the range.

How long does it typically take a new pediatric clinic to break even? It depends on how the fixed costs (rent, core salaries, cold-chain equipment) compare against a schedule-driven revenue line that's more forecastable here than in acquisition-heavy specialties, but still seasonal. No single break-even timeline applies across every clinic size and city tier.

What is the biggest cost driver in a pediatric clinic's monthly overhead? Clinician time, not equipment. There's no OT or imaging stack to fund, so the recurring cost sits in space built for children and parents, longer consultation slots, and the cold chain, with clinician hours setting the ceiling on how much revenue that overhead can support.

Does adding pediatric dentistry or nutrition services meaningfully change revenue? It can, mainly by giving the clinic additional billable lines beyond consultation and immunisation. Clinics near the top of the ₹18 L–₹1.8 Cr range typically carry more than one of these added services rather than relying on OPD volume alone.

How much does seasonal illness volume affect a pediatric clinic's monthly cash flow? Respiratory and infectious presentations cluster at certain times of year, so monthly revenue is uneven even when the annual figure looks stable. An owner budgeting on a flat monthly average will misjudge cash flow in the leaner months.

What licensing costs apply to a pediatric clinic beyond standard Clinical Establishments Act registration? Biomedical waste authorisation applies alongside CEA registration, covering how clinical waste is segregated and handled. Neither the CEA portal nor the government's biomedical waste release publishes a fixed fee figure, so this should be confirmed with the relevant state authority before the clinic opens.

Is patient retention or new patient acquisition the bigger revenue lever for a pediatric clinic? Retention. A patient acquired in infancy returns on a knowable schedule for years, which makes lifetime value across that visit calendar a bigger driver of revenue than the cost of acquiring any single new patient.

Written by Rohit Gupta, Co-Founder, Business & Growth Reviewed by Sabhyaa Gupta, ops and delivery lead

Neither the author nor the reviewer is a clinician; this is a business and marketing-economics analysis, not clinical advice, and nothing here is guidance on immunisation practice.